Repository logo
 

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study.

Accepted version
Peer-reviewed

Change log

Authors

Padilla, Concepcion  ORCID logo  https://orcid.org/0000-0003-4102-6787
Montal, Victor 
Walpert, Madeleine J 
Hong, Young T 
Fryer, Tim D 

Abstract

Introduction: The Down syndrome population has a high prevalence for dementia, often showing their first clinical symptoms in their 40s. Methods: In a longitudinal cohort, we investigate whether amyloid deposition at time point 1 (TP1) could predict cortical thickness change at time point 2 (TP2). The association between tau burden and cortical thickness was also examined at time point 3 (TP3). Results: Between TP1 and TP2 there was pronounced cortical thinning in temporo-parietal cortices and cortical thickening in the frontal cortex. Baseline amyloid burden was strongly associated to cortical thinning progression, especially in the temporo-parietal regions. At TP3, tau deposition negatively correlated with cortical atrophy in regions where tau usually accumulates at later Braak stages. Discussion: A higher amount of amyloid accumulation triggers a cascade of changes of disease-causing processes that eventually lead to dementia. As expected, we found that regions where tau usually accumulates were those also displaying high levels of cortical atrophy.

Description

Keywords

Alzheimer's disease, Down syndrome, amyloid deposition, cortical atrophy, longitudinal, tau deposition

Journal Title

Alzheimers Dement (Amst)

Conference Name

Journal ISSN

2352-8729
2352-8729

Volume Title

Publisher

Wiley Open Access
Sponsorship
Medical Research Council (MR/K02308X/1)
This research was generously supported by different grants from the Medical Research Council (grant ID number: 98480), the Alzheimer’s Research UK (grant ID number: ARUK-PG2015-23), and the National Institute of Health of the USA (grant ID number: U01AG051406-01 Neurodegeneration in Aging Down Syndrome, NiAD). Additional support came from the NIHR Cambridge Biomedical Research Centre, the NIHR Collaborations in Leadership for Applied Health Research and Care (CLAHRC) for the East of England, the NIHR Cambridge Dementia Biomedical Research Unit, the Down Syndrome Association, and the Health Foundation.